FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2159969974> ?p ?o ?g. }

• W2159969974 endingPage "541" @default.
• W2159969974 startingPage "533" @default.
• W2159969974 abstract "Ten years have elapsed since the International Agency for Research on Cancer (IARC) evaluated the carcinogenicity of chromium and chromium compounds. Further studies performed during the last decade have provided further epidemiological, experimental and mechanistic data which support the IARC conclusions. A wealth of results indicate that, at variance with chromium(0) and chromium(III), chromium(VI) can induce a variety of genetic and related effects in vitro. The lack of carcinogenicity of chromium(0) and chromium(III) compounds in experimental animals is well established, and only a minority of animal carcinogenicity data with chromium(VI) compounds were positive (30 out of 70, i.e. 42.9%). Moreover, most positive studies used administration routes which do not mimic any human exposure and by-pass physiological defense mechanisms. Typically, positive results were only obtained at implantation sites and at the highest dose tested. Exposure to chromium(VI) has been known for more than a century to be associated with induction of cancer in humans. Carcinogenicity requires massive exposures, as is only encountered in well defined occupational settings, and is site specific, being specifically targeted to the lung and, in some cases, to the sinonasal cavity. Increased death rates for cancers at other sites, which were occasionally reported in some epidemiological studies, were almost invariably not statistically significant, and inconsistent (being counterbalanced by other studies which apparently showed decreased rates for the same cancers). As we recently quantified in human body compartments, chromium(VI) can be reduced in body fluids and non-target cells, which results in its detoxification, due to the poor ability of chromium(III) to cross cell membranes. In target cells, chromium(VI) tends to be metabolized by a network of mechanisms leading to generation of reduced chromium species and reactive oxygen species, which will result either in activation or in detoxification depending on the site of the intracellular reduction and its proximity to DNA. When introduced by the oral route, chromium(VI) is efficiently detoxified upon reduction by saliva and gastric juice, and sequestration by intestinal bacteria. If some chromium(VI) is absorbed by the intestine, it is massively reduced in the blood of the portal system and then in the liver. These mechanisms explain the lack of genotoxicity, carcinogenicity, and induction of other long-term health effects of chromium (VI) by the oral route. Within the respiratory tract, chromium(VI) is reduced in the epithelial-lining fluid, pulmonary alveolar macrophages, bronchial tree and peripheral lung parenchyma cells. Hence, lung cancer can only be induced when chromium(VI) doses overwhelm these defense mechanisms. The efficient uptake and reduction of chromium(VI) in red blood cells explains its lack of carcinogenicity at a distance from the portal of entry into the body. All experimental and epidemiological data, and the underlying mechanisms, point to the occurrence of thresholds in chromium(VI) carcinogenesis." @default.
• W2159969974 created "2016-06-24" @default.
• W2159969974 creator A5086487964 @default.
• W2159969974 date "2000-04-01" @default.
• W2159969974 modified "2023-10-09" @default.
• W2159969974 title "Threshold mechanisms and site specificity in chromium(VI) carcinogenesis" @default.
• W2159969974 cites W139289893 @default.
• W2159969974 cites W1969312348 @default.
• W2159969974 cites W1971097440 @default.
• W2159969974 cites W1977194688 @default.
• W2159969974 cites W1977208375 @default.
• W2159969974 cites W1977235823 @default.
• W2159969974 cites W1980764102 @default.
• W2159969974 cites W1982234959 @default.
• W2159969974 cites W1987260158 @default.
• W2159969974 cites W1987466062 @default.
• W2159969974 cites W1993163605 @default.
• W2159969974 cites W1994868809 @default.
• W2159969974 cites W1996870155 @default.
• W2159969974 cites W2009529498 @default.
• W2159969974 cites W2010547533 @default.
• W2159969974 cites W2012837757 @default.
• W2159969974 cites W2012976406 @default.
• W2159969974 cites W2014459313 @default.
• W2159969974 cites W2014628448 @default.
• W2159969974 cites W2015423277 @default.
• W2159969974 cites W2022320336 @default.
• W2159969974 cites W2025917991 @default.
• W2159969974 cites W2031577784 @default.
• W2159969974 cites W2033950810 @default.
• W2159969974 cites W2045335213 @default.
• W2159969974 cites W2051522390 @default.
• W2159969974 cites W2054483918 @default.
• W2159969974 cites W2056656963 @default.
• W2159969974 cites W2073565251 @default.
• W2159969974 cites W2079813915 @default.
• W2159969974 cites W2080485663 @default.
• W2159969974 cites W2080751156 @default.
• W2159969974 cites W2084947612 @default.
• W2159969974 cites W2089665842 @default.
• W2159969974 cites W2089756064 @default.
• W2159969974 cites W2090255320 @default.
• W2159969974 cites W2099604330 @default.
• W2159969974 cites W2104181780 @default.
• W2159969974 cites W2104510909 @default.
• W2159969974 cites W2105426204 @default.
• W2159969974 cites W2115736396 @default.
• W2159969974 cites W2117281806 @default.
• W2159969974 cites W2127064404 @default.
• W2159969974 cites W2130546974 @default.
• W2159969974 cites W2130848729 @default.
• W2159969974 cites W2146960775 @default.
• W2159969974 cites W2154563160 @default.
• W2159969974 cites W2162403933 @default.
• W2159969974 cites W2166911769 @default.
• W2159969974 cites W2168615268 @default.
• W2159969974 doi "https://doi.org/10.1093/carcin/21.4.533" @default.
• W2159969974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10753182" @default.
• W2159969974 hasPublicationYear "2000" @default.
• W2159969974 type Work @default.
• W2159969974 sameAs 2159969974 @default.
• W2159969974 citedByCount "293" @default.
• W2159969974 countsByYear W21599699742012 @default.
• W2159969974 countsByYear W21599699742013 @default.
• W2159969974 countsByYear W21599699742014 @default.
• W2159969974 countsByYear W21599699742015 @default.
• W2159969974 countsByYear W21599699742016 @default.
• W2159969974 countsByYear W21599699742017 @default.
• W2159969974 countsByYear W21599699742018 @default.
• W2159969974 countsByYear W21599699742019 @default.
• W2159969974 countsByYear W21599699742020 @default.
• W2159969974 countsByYear W21599699742021 @default.
• W2159969974 countsByYear W21599699742022 @default.
• W2159969974 countsByYear W21599699742023 @default.
• W2159969974 crossrefType "journal-article" @default.
• W2159969974 hasAuthorship W2159969974A5086487964 @default.
• W2159969974 hasBestOaLocation W21599699741 @default.
• W2159969974 hasConcept C114246631 @default.
• W2159969974 hasConcept C121608353 @default.
• W2159969974 hasConcept C126322002 @default.
• W2159969974 hasConcept C142724271 @default.
• W2159969974 hasConcept C178790620 @default.
• W2159969974 hasConcept C185592680 @default.
• W2159969974 hasConcept C2776256026 @default.
• W2159969974 hasConcept C2909514155 @default.
• W2159969974 hasConcept C29730261 @default.
• W2159969974 hasConcept C2993769243 @default.
• W2159969974 hasConcept C33070731 @default.
• W2159969974 hasConcept C42407357 @default.
• W2159969974 hasConcept C511782168 @default.
• W2159969974 hasConcept C55493867 @default.
• W2159969974 hasConcept C555283112 @default.
• W2159969974 hasConcept C71924100 @default.
• W2159969974 hasConcept C86803240 @default.
• W2159969974 hasConceptScore W2159969974C114246631 @default.
• W2159969974 hasConceptScore W2159969974C121608353 @default.
• W2159969974 hasConceptScore W2159969974C126322002 @default.
• W2159969974 hasConceptScore W2159969974C142724271 @default.

• next